Replies to post #218376 on Cytodyn Inc (CYDY)

[justdafactss]

Wheres the primary endpoint data?

CytoDyn plans to publish soon the safety and efficacy data in which it met its primary endpoint, in its Phase 2b/3 randomized, double-blinded, placebo-controlled trial for the HIV-MDR population, in a peer-reviewed journal.
https://www.sec.gov/Archives/edgar/data/1175680/000155837022015602/cydy-20221028xex99d1.htm

Cyrus said the primary endpoints were met right?

RIGHT?

Cyrus Arman, Ph.D., President of CytoDyn, stated, "We have decided to voluntarily withdraw our BLA for the HIV-MDR population at this time only after extensive review and deliberation, including audits from three external independent regulatory quality firms. While the Company met its primary endpoints in these pivotal trials
https://www.sec.gov/Archives/edgar/data/1175680/000155837022015602/cydy-20221028xex99d1.htm